Cite
HARVARD Citation
Hondelink, L. et al. (2023). Prevalence, clinical and molecular characteristics of early stage EGFR-mutated lung cancer in a real-life West-European cohort: Implications for adjuvant therapy. European journal of cancer. pp. 53-61. [Online].